KEYNOTE-716: DMFS and RFS Update
Phase III KEYNOTE-716 Update: Final DMFS Analysis of Adjuvant Pembrolizumab vs Placebo in Stage IIB/IIC Melanoma

Released: June 12, 2023

Activity

Progress
1
Course Completed